62
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study

, , , , , , , , , , & show all
Pages 1589-1603 | Published online: 06 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Fisayo A. Olotu, Clement Agoni, Opeyemi Soremekun & Mahmoud E. S. Soliman. (2020) The recent application of 3D-QSAR and docking studies to novel HIV-protease inhibitor drug discovery. Expert Opinion on Drug Discovery 15:9, pages 1095-1109.
Read now
A Antinori, S Rusconi, N Gianotti, T Bini, D Mancusi & R Termini. (2019) Cardiovascular adverse events during treatment with darunavir-based regimens in an Italian observational study. Drug Design, Development and Therapy 13, pages 1667-1685.
Read now
Stéphane De Wit, Eric Florence, Linos Vandekerckhove, Bernard Vandercam, Jean-Christophe Goffard, Eric Van Wijngaerden, Michel Moutschen, Remy Demeester, Pushpike Thilakarathne & Hilde Piryns. (2018) Long-term use of darunavir/ritonavir-containing regimens in daily practice in Belgium: retrospective observational cohort data of 1701 HIV-patients. Acta Clinica Belgica 73:5, pages 341-347.
Read now